Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy

CAMBRIDGE, Mass. (May 22, 2012) – Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part of this system, heat shock protein 90 (HSP90) has been shown to help malignant cells accommodate the genetic changes and profound disturbances in normal biology that occur in cancers.
read more

share

Copyright © 2011 Regator, LLC